Position in ABVX
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$634,695
New position
Shares Held
5,700
first reported quarter
Ownership
0.007%
of shares outstanding
% of Portfolio
0.96%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Derivatives in ABVX
reported options exposure · as of Mar 31, 2026CallValue
$1,458,685
CallShares
13,100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026T3 Companies, LLC holds $2,219,191 across 9 Biotechnology names. ABVX ranks #1 (28.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
This page
|
5,700 | $634,695 | |
| 2 | VYNE |
VYNE Therapeutics Inc.
|
945,000 | $565,110 | |
| 3 | SEER |
Seer, Inc.
|
170,962 | $287,216 | |
| 4 | IFRX |
InflaRx N.V.
|
291,014 | $260,166 | |
| 5 | NRXS |
Neuraxis, INC
|
29,921 | $221,415 | |
| 6 | SANA |
Sana Biotechnology, Inc.
|
33,800 | $97,344 | |
| 7 | CBUS |
Cibus, Inc.
|
48,500 | $96,030 | |
| 8 | COCP |
Cocrystal Pharma, Inc.
|
51,500 | $52,015 |
All Filings in ABVX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $634,695 | 5,700 | Shares | Sole | 2026-05-07 | |
| 2026-03-31 | $1,458,685 | 13,100 | Call | Sole | 2026-05-07 | |
| No filing history on record for this holder in this stock. | ||||||